Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Khalid S.

United Kingdom

USD 100 /hr

Expert in CRISPR/Cas9, molecular and cell biology, organoid, immunology, precision cancer research

Profile Summary

As Senior scientist,involved in a variety of genome-wide/bespoke library CRISPR based projects including immunology

Subject Matter Expertise

• ☆ Immunoassay
• ☆ Molecular Biology
• ☆ Genetics
• ☆ Genomics
• ☆ Molecular Cloning
• ☆ Next Generation Sequencing (NGS)
• ☆ DNA Sequencing
• ☆ Gene Expression Analysis
• ☆ Genome Sequencing
• ☆ Exome Sequencing
• ☆ Recombinant DNA
• ☆ RNA Sequencing
• ☆ DNA/Gene Synthesis
• ☆ Oligonucleotide Synthesis
• ☆ Plasmid DNA
• ☆ ChIP-Seq
• ☆ Cell Biology
• ☆ Cell-Based Assays
• ☆ Stem Cell Research
• ☆ Gene Editing/CRISPR
• ☆ Phylogenetics
• ☆ Drug Development
• ☆ Pharmacogenomics
• ☆ Immunogenetics
• ☆ Immunotherapy
• ☆ Cancer Research
• ☆ Cancer Biology
• ☆ Carcinogenesis
• ☆ Technical & Scientific Writing
• ☆ Manuscript & Journal Article Writing
• ☆ Experimental Protocols
• ☆ SOP & Protocol Writing
• ☆ Grant Writing

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Technical Writing

Research User Research, Scientific and Technical Research

Consulting Healthcare Consulting, Scientific and Technical Consulting

Data & AI Data Visualization

Work Experience

Senior Scientist

Cancer Research UK Cambridge Research Institute

September 2019 - Present

Researcher

Helsingin Yliopisto

February 2018 - August 2019

Postdoctoral Fellow

University of Helsinki

January 2018 - August 2019

Education

PhD (Institute for Molecular Medicine Finland FIMM)

University of Helsinki

March 2010 - August 2018

Certifications

• Certification details not provided.

Publications

PREPRINT

Khalid Saeed, Jun Dai, Shuyu Zheng, Matías M. Falco, Jie Bao, Johanna Eriksson, Fernando Perez-Villatoro, Anniina Färkkilä, Olli Dufva, Satu Mustjoki, et al. (2022). Tracing back primed resistance in cancer via sister cells .

JOURNAL ARTICLE

Khalid Saeed, Poojitha Ojamies, Teijo Pellinen, Samuli Eldfors, Riku Turkki, Johan Lundin, Petrus Järvinen, Harry Nisen, Kimmo Taari, Taija M. af Hällström, et al.(2019). Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells . International Journal of Cancer. Wiley

Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions.

comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancers.